Skip to main content

Table 1 Different expressed peptides between newly diagnosed ALL and healthy controls

From: Serum peptidome based biomarkers searching for monitoring minimal residual disease in adult acute lymphocytic leukemia

Index Mass Dave PWKW Ave1 Ave2 StdDev1 StdDev2 Expression Change
61 9288.31 2.32 < 0.000001 1.31 3.63 0.28 1.87
27 3443.92 1.1 < 0.000001 1.54 2.64 0.66 0.9
41 4249.06 0.76 0.000007 1.7 2.46 0.62 0.49
13 2661.27 20.95 < 0.000001 28.39 7.44 22.56 3.69
43 4645.31 1.74 0.00000373 1.67 3.41 1.09 1.75
7 1945.51 1.06 0.00000114 2.01 3.06 0.39 1.12
8 2093.83 1.15 0.0000791 3.38 2.23 1.38 0.44
33 4072.42 0.4 0.00175 1.59 1.99 0.43 0.4
35 4108.67 0.45 0.00129 1.66 2.1 0.53 0.41
28 3884.26 0.85 0.000281 1.65 2.5 0.82 1.02
4 1546.94 5.98 0.000942 10.48 4.5 8.72 2.57
12 2644.19 0.86 0.001 2.93 2.07 1.23 0.5
36 4123.33 0.42 0.00445 1.7 2.13 0.54 0.43
62 9367.9 1.28 0.0108 0.95 2.23 0.41 1.2
11 2561.9 1.28 0.000009 3.07 1.79 1.97 0.49
21 2991.46 5.28 < 0.000001 17.24 1.96 8.54 0.63
34 4091.61 1.46 0.00622 3.16 4.62 1.55 1.93
58 7764.29 1.3 0.00000217 1.39 2.68 0.7 1.44
10 2545.82 0.92 0.00619 2.98 2.06 1.53 0.47
46 5064.98 0.33 0.0374 1.11 1.44 0.27 0.53
2 1466.84 5.01 0.000639 8.46 3.46 4.84 2.44
1 1450.14 1 0.0163 4.09 3.1 1.72 0.68
57 7025.82 0.69 0.00913 0.83 1.52 0.35 1.23
14 2673.64 1.7 0.00626 4.04 2.34 1.22 0.53
42 4266.78 1 0.0154 2.56 3.57 1.22 1.6
18 2900.77 0.89 0.0288 2.62 1.74 1.71 0.48
5 1618.2 3.56 0.0000421 6.76 3.19 4.43 1.65
3 1526.98 1.92 0.0107 4.29 2.37 2.03 0.61
38 4169.26 0.43 0.0146 2.04 2.46 0.81 0.54
39 4194.35 0.71 0.0173 2.88 3.59 1.35 1.01
29 3891.28 0.44 0.0285 1.83 0.77 0.86 0.17
22 3192.79 0.38 0.00906 2.03 2.4 1.19 0.78
25 3263.65 0.84 0.00446 2.98 3.82 1.7 1.75
  1. Index: Peptide peak index; Mass: Mass to charge ratio value; Dave: Differences of average peak intensity between newly diagnosed ALL group and healthy control group; P value: p value of Wilcoxon test; Ave1: Average peak intensity of newly diagnosed ALL group; Ave2: Average peak intensity of healthy control group; StdDev1: Standard deviation of the peak intensity average of newly diagnosed ALL group; StdDev2: Standard deviation of the peak intensity average of healthy control group.